HDAC6 and Parkinson disease: The effects of non-enzyme activity (i.e., ubiquitin-binding activity) of HDAC6 on PD pathogenesis have been reported (Du et al., 2010), but the role of its enzymatic activity (i.e., the deacetylation activity) on PD pathogenesis remains unclear.